1. Home
  2. SPNS vs NVAX Comparison

SPNS vs NVAX Comparison

Compare SPNS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPNS
  • NVAX
  • Stock Information
  • Founded
  • SPNS 1982
  • NVAX 1987
  • Country
  • SPNS Israel
  • NVAX United States
  • Employees
  • SPNS N/A
  • NVAX N/A
  • Industry
  • SPNS Computer Software: Prepackaged Software
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SPNS Technology
  • NVAX Health Care
  • Exchange
  • SPNS Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • SPNS 1.6B
  • NVAX 1.3B
  • IPO Year
  • SPNS 1992
  • NVAX 1995
  • Fundamental
  • Price
  • SPNS $27.41
  • NVAX $6.65
  • Analyst Decision
  • SPNS Buy
  • NVAX Buy
  • Analyst Count
  • SPNS 4
  • NVAX 6
  • Target Price
  • SPNS $34.25
  • NVAX $15.33
  • AVG Volume (30 Days)
  • SPNS 184.9K
  • NVAX 4.8M
  • Earning Date
  • SPNS 08-13-2025
  • NVAX 08-06-2025
  • Dividend Yield
  • SPNS 2.19%
  • NVAX N/A
  • EPS Growth
  • SPNS 11.11
  • NVAX N/A
  • EPS
  • SPNS 1.30
  • NVAX 2.97
  • Revenue
  • SPNS $544,235,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • SPNS $8.25
  • NVAX $52.02
  • Revenue Next Year
  • SPNS $6.85
  • NVAX N/A
  • P/E Ratio
  • SPNS $21.68
  • NVAX $2.24
  • Revenue Growth
  • SPNS 3.84
  • NVAX 25.92
  • 52 Week Low
  • SPNS $23.69
  • NVAX $5.01
  • 52 Week High
  • SPNS $39.99
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • SPNS 33.52
  • NVAX 42.37
  • Support Level
  • SPNS $28.59
  • NVAX $6.93
  • Resistance Level
  • SPNS $29.31
  • NVAX $8.46
  • Average True Range (ATR)
  • SPNS 0.56
  • NVAX 0.34
  • MACD
  • SPNS -0.30
  • NVAX -0.05
  • Stochastic Oscillator
  • SPNS 1.17
  • NVAX 1.09

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: